SEC Form 4 · accession 0000939767-17-000023
EXELIXIS, INC. · EXEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Poste
Director
Period of report
Mar 1, 2017
Accepted (ET)
Mar 3, 2017 · 8:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000939767
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 1, 2017 | M | 8,850 | $10.53 | A | 86,405 | D | |
| Common StockF1 | Mar 1, 2017 | S | 8,850 | $22.18 | D | 77,555 | D | |
| Common Stock | Mar 2, 2017 | M | 1,150 | $10.53 | A | 78,705 | D | |
| Common Stock | Mar 2, 2017 | M | 40,000 | $3.13 | A | 118,705 | D | |
| Common Stock | Mar 2, 2017 | M | 11,250 | $4.16 | A | 129,955 | D | |
| Common Stock | Mar 2, 2017 | M | 15,000 | $7.97 | A | 144,955 | D | |
| Common StockF2 | Mar 2, 2017 | S | 67,400 | $22.58 | D | 77,555 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F3 | $10.53 | Mar 1, 2017 | M | 8,850 | D | May 2, 2007 | May 1, 2017 | Common Stock | 8,850 | 1,150 | D |
| Option (right to buy)F3 | $10.53 | Mar 2, 2017 | M | 1,150 | D | May 2, 2007 | May 1, 2017 | Common Stock | 1,150 | 0 | D |
| Option (right to buy)F4 | $3.13 | Mar 2, 2017 | M | 40,000 | D | May 28, 2015 | May 27, 2022 | Common Stock | 40,000 | 0 | D |
| Option (right to buy)F5 | $4.16 | Mar 2, 2017 | M | 11,250 | D | May 14, 2009 | May 13, 2019 | Common Stock | 11,250 | 0 | D |
| Option (right to buy)F6 | $7.97 | Mar 2, 2017 | M | 15,000 | D | May 2, 2008 | May 1, 2018 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.15 to $22.24. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
- F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.40 to $22.78. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
- F3The option, representing the right to purchase a total of 10,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2007.
- F4The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 28, 2015.
- F5The option, representing the right to purchase a total of 11,250 shares of Exelixis, Inc. common stock, became fully exercisable on May 14, 2009.
- F6The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2008.